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A B S T R A C T

Lymphoma involves malignancy of the lymphatic system which includes the spleen, thymus, bone marrow and
lymph nodes. Diffuse large B-cell lymphoma (DLBCL) is an aggressive, rapidly-growing type of non-Hodgkin lymphoma (NHL). We present a case of an 18-year-old male who initially presented with right hindfoot pain and
swelling. Initial radiographs revealed no osseous pathology that correlated with the area of pain and swelling.
Magnetic resonance imaging (MRI) was obtained which revealed a large soft tissue mass surrounding the calcaneus with cortical erosion and complete marrow replacement of the calcaneus. Due to concern for malignancy,
the patient underwent a ﬂuoroscopic-guided biopsy of the calcaneus. The pathology report revealed large atypical
lymphoid inﬁltrates that were positive for B-cell molecular markers, CD20 and PAX5, consistent with the diagnosis of B-cell lymphoma. Initial positron emission tomography (PET) scan demonstrated hypermetabolism at the
right foot, right popliteal fossa and right inguinal region which was consistent with Diffuse Large B-cell lymphoma, Grade 3B, Stage I or II. The patient underwent 6 cycles of chemotherapy. The patient’s pain and swelling
to the hindfoot had completely resolved and the patient remains in remission.

Introduction
Lymphoma usually occurs when cells, speciﬁcally lymphocytes, grow
uncontrollably within the lymphatic system, speciﬁcally in the lymph
nodes. Lymphoma can be divided broadly into Hodgkin’s Lymphoma
(HL) and non-Hodgkin’s lymphoma (NHL) with NHL being more common. Diffuse large B-cell lymphoma (DLBCL) is an aggressive, rapidlygrowing type of NHL. DLCBL is the most common subtype and constitutes approximately 30% of all NHLs.1,2,3 DLBCL can affect patients of
all ages; however, most patients are over the age of 60 at diagnosis and
are predominantly male (55%).4,5,6 DLBCL can begin in the lymph nodes
or in extranodal sites such as the central nervous system, gastrointestinal
tract, liver, bone or basically any organ of the body.1,4,7 Often DLBCL has
an extranodal presentation rather than presenting with a symptomatic
rapidly enlarging mass due to enlarged lymph nodes.1,2
There are many non-speciﬁc symptoms associated with DLBCL that
vary from mild general pain to soft tissue swelling, sometimes with systemic symptoms also known as B symptoms (fever, night sweats and
unintentional weight loss). According to Park et al, bones that are
involved with DLBCL include the femur (27%), pelvis (15%), tibia/ﬁbula
(13%), humerus (12%), spine (9%), mandible (2%), radius/ulna (1%),
scapula (1%), skull (1%) and bones of the hands and feet were uncommonly involved.8 Lymphoma can inﬁltrate any organ in the body

including bone with bone marrow involvement present in approximately
50% to 80% of patients with low grade NHL and 25% to 40% of those
with high-grade NHL.9,10
Although NHL is a common type of lymphoma in adults, it is a relatively uncommon pedal neoplasm.11 In this report, we present a case of
an 18 year old male who was diagnosed with diffuse large B-cell lymphoma with an initial extranodal presentation. With the aid of MRI, the
painful hindfoot was further evaluated and was highly suspicious for
malignancy. Therefore, surgical biopsies were obtained with ﬁnal pathological diagnosis of DLBCL.

Case report
An 18-year-old male who was referred to the senior author with an 8
month history of right hindfoot swelling and pain with walking and
standing. He denied any injuries or previous trauma to the right lower
extremity. The patient denied any constitutional symptoms including
unintentional weight loss, night sweats or fever. The patient did admit
to decrease in appetite. His medical history and surgical history were
unremarkable. He had no known drug allergies and was not taking any
medication. His family history was not signiﬁcant for cancer. He denied
using any tobacco products, illicit drugs or alcohol.
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Physical examination of his right foot revealed normal, full, pain-free
range of motion of the metatarsophalangeal, ankle and subtalar joints.
No crepitus was noted at the subtalar or ankle joints. Pain was noted on
direct palpation of the lateral calcaneal wall, peroneal tendons and slight
pain was noted at the sinus tarsi region. Moderate non-pitting edema,
erythema and ecchymoses was noted to the lateral aspect of the right
hindfoot (Fig. 1). Neurovascular examination was within normal limits.
The radiographic examination consisted of multiple views of the foot
and ankle, which revealed no osseous pathology that correlated with the
area of pain and swelling. No radiographic evidence of osteolysis or sclerotic lesions of the calcaneus. No acute fractures were seen. The ankle
joint appeared stable, with no cortical erosion, periosteal reaction or cortical wall break. MRI of the right hindfoot revealed a large soft tissue
mass surrounding the calcaneus that encased the ﬂexor hallucis longus
tendon and extended into the quadratus plantae muscle. There was cortical erosion of the calcaneus at the peroneal tubercle, lateral and superior
aspects of the calcaneal tuberosity and complete marrow replacement of
the calcaneus (Fig. 2).
The patient was brought into the operating room and placed on the
operating room table in the supine position. Anesthesia was administered and the right lower extremity was prepped and draped in the usual
aseptic manner. A palpable soft tissue mass was noted on the lateral
aspect of the right hindfoot superior to the calcaneus along the peroneal
tendons measuring 8.0 cm x 6.0 cm as outlined intra-operatively
(Fig. 3). A trephine was used to obtain bone from the calcaneus for the
biopsy at the level of cystic changes which was conﬁrmed with intraoperative ﬂuoroscopy (Fig. 4). The specimens, including bone and soft
tissue, were sent for evaluation, both microbiology and pathology.
Cultures including acid fast stain and Grocott methenamine silver
(GMS) stain for fungal elements were negative. Histologic slides showed
large atypical lymphoid inﬁltrate with necrotic cellular debris (Fig. 5A).
Immunophenotyping and histochemical stains were positive for B-cell
molecular markers including CD20 and PAX5 but were CD99 negative
(Fig. 5B,C,D). Fluorescence in situ hybridization (FISH), a molecular
cytogenetic test used to distinguish DLBCL from other lymphomas was
negative. All these ﬁndings led to a diagnosis that was highly suspicious
for B-cell lymphoma. The patient was referred to orthopedic oncology
who evaluated the patient and referred the patient to medical oncology.
Initial staging PET scan demonstrated hypermetabolism at the right
foot, right popliteal fossa and right inguinal region which was consistent
with Diffuse Large B-cell lymphoma, Grade 3B, Stage I or II. Fertility
preservation was completed and then he began 6 cycles of chemotherapy consisting of rituximab, cyclophosphamide, doxorubicin and
vincristine, known as R-CHOP. After 6 cycles, repeat PET scan demonstrated complete response to therapy with no evidence of disease. At his
followup appointment 12 months since diagnosis, new radiographs of
the right foot were obtained which demonstrated no osseous pathology
as seen in Figure 6. Clinically, the right foot was within normal limits

Fig. 2. A, T1 weighted image demonstrating surrounding soft tissue mass. B, T1
weighted image demonstrating complete marrow replacement of the calcaneus.
C, T2 weighted image demonstrates cystic areas within the calcaneus and cortical wall erosion.

Fig. 3. Palpable soft tissue mass outlined on the lateral hindfoot extending along
the peroneal tendons. Bone biopsy site (arrow).

Fig. 1. Nonpitting edema with ecchymoses noted to the lateral aspect of the
hindfoot.
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Fig. 4. A, Trephine was used to retrieve a small sample of calcaneus and sent to
microbiology and pathology for evaluation. B, Trephined sample of calcaneus
that was sent for evaluation.

Fig. 6. A, Anteroposterior foot view and B, lateral ankle view of patient at 12
months postoperatively highlighting no cortical erosion.

Fig. 7. Right hindfoot 12 months since diagnosis of Diffuse Large B-Cell Lymphoma. No edema or ecchymoses noted.

with no edema or ecchymoses present (Fig. 7). Patient is currently in
remission, denies any pain to the right lower extremity and has returned
to all activities.
Discussion
Lymphoma is not uncommon and musculoskeletal symptoms may be
the key to an early diagnosis. Lymphoma is a category of cancers that
affects the lymphatic system. The two main kinds of lymphoma are
Hodgkin’s Lymphoma which spreads in an organized manner from one
group of lymph nodes to another, and non-Hodgkin’s lymphoma which
spreads through the lymphatic system in a non-organized manner.10
DLBCL, the most common type of NHL, varies clinically and current
treatment protocols involve combinations of immunotherapy and
chemotherapy.11,12 Once a neoplasm has been identiﬁed it is important

Fig. 5. A, H&E stain with neoplastic B cells. B, CD20 positive. CD 20 is a membrane-embedded surface molecule which plays a role in the development and
differentiation of B-cells into plasma cells. C, PAX5 positive. PAX5 is a transcription factor that encodes the B-cell lineage speciﬁc activator protein that is
expressed at early, but not late stages of B-cell differentiation. D, CD99 positive.
Transmembrane protein that plays a role in actin cytoskeleton arrangement.
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haematologic spread.13 With this particular case presentation, as would
be true for any type of cancer, it is imperative to obtain further diagnostic imaging with persistent symptoms, obtain a biopsy for deﬁnitive
diagnosis and treatment should use a multidisciplinary approach.

to perform a thorough history and physical examination with a focus on
constitutional symptoms as well as identify if any other locations are
involved.6 Depending on the location, size, appearance of the neoplasm
and growth rate, treatment protocols will vary and often involves a
multi-disciplinary team of medical oncology, radiation oncology, surgery, radiology and pathology.
Radiographic features of lymphoma involving osseous structures are
variable and sometimes can appear normal, lytic or sclerotic. If visible
on radiographs they can produce a “moth-eaten” appearance.6,13 There
is often a surrounding soft-tissue mass and sometimes there is a cortical
break that can lead to pathological fractures. Other imaging modalities
can be very useful such as bone scan or MRI as lymphoma involving
bones can have a normal or very subtle appearance on radiographs.6,13
As with the presented case, further imaging for symptomatic patients
with normal radiographs is required to diagnose marrow disease.13 MRI
plays an important role in the diagnosis of lymphoma involving the
bones, showing high sensitivity for marrow replacement.13 When the
bone marrow is replaced by a tumor it will show low intensity on T1weighted images and high intensity on T2-weighted images.6,13 PET
scans also play an integral role in the initial staging of lymphoma,
detecting other sites that may not be seen on other imaging modalities
as well as treatment response. PET scan has an advantage over CT/MRI
because of its ability to decipher between active, viable tumor and
necrotic tumor that have responded well to treatment.13
The etiology of lymphoma is not fully understood but there have
been links to lymphoma to certain viral infections, for example, human
immunodeﬁciency virus (HIV) and Epstein Barr virus.10 Two molecular
subtypes of DLBCL have been accepted including the germinal center Bcell (GCB) type and the activated B-cell form (ABC) which are associated
with speciﬁc genetic alterations, different molecular signaling pathways
and different clinical outcomes.10 According to Schneider et al., most
DLBCLs derive from germinal center B-cells which are secondary lymphoid tissues.12 These germinal centers (GC) have proliferating B-cells
that develop into plasma cells that produce antibodies and memory B
cells that provide protection from infections with re-invading organisms.12 Certain genetic variations that have been found in DLBCL
include chromosomal translocations, sporadic somatic mutations and
copy number alterations, denoted by deletions or ampliﬁcations.12 Additional subtypes of DLBCL has been recognized by the World Health
Organization (WHO) which includes EBV-positive DLBCL and DLBCL
associated with chronic inﬂammation.10
The skeletal system is an uncommon site of lymphoma involvement
and DLBCL is rarely found in the foot and ankle. When lymphoma occurs
within the musculoskeletal system it likely represents secondary
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